NEXGEL, INC.
No SEC Form 4 filings for $NXGL in the last 30 days.
See all $NXGL insider activity →NEXGEL, Inc. (NXGL) announced a 1-for-20 reverse stock split, effective October 12, 2026. The split reduces outstanding shares from 9,747,663 to approximately 487,384, aiming to meet Nasdaq's $1.00 minimum bid price requirement. Trading continues under the symbol 'NXGL' on the Nasdaq Capital Market.
NEXGEL, Inc. (NXGL) affiliate Adam R. Levy proposed selling 227,956 shares, valued at $41,214, and 21,500 shares, valued at $3,488.98, with sales expected around September 2026. Levy acquired shares via open-market purchases and stock grants from 2019 to 2025.
NEXGEL, INC. (NXGL) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. On September 23, 2026, NexGel, Inc. (the “Company” ) held its 2026 Special Meeting of Stockholders (the “Special Meeting” ). At the Special Meeting, there were 6,200,043 shares of common stock represented in person o
Over the past 7 days, AlphAI's AI scored 4 news stories mentioning NXGL (NEXGEL, INC.). Coverage has skewed bearish: 0 bullish, 3 neutral, and 1 bearish.
Recent NXGL coverage spans corporate actions, earnings and financial news.
Reverse split starts trading on a split-adjusted basis, which can change liquidity, per-share price optics, and compliance optics.
The disclosed sale may create modest selling pressure on Nexgel shares.
Potential dilution and future reverse split could affect share price and float.
Leadership transition may cause short‑term volatility and affect execution of strategic initiatives.
Results show revenue growth but continued losses tied to integration and recall-related charges, likely keeping near-term sentiment pressured.
AlphAI scores every news story that mentions NXGL with an AI model for sentiment and relevance, and aggregates insider trades from NEXGEL, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
NEXGEL, Inc. (NXGL) announced a 1-for-20 reverse stock split, effective October 12, 2026. The split reduces outstanding shares from 9,747,663 to approximately 487,384, aiming to meet Nasdaq's $1.00 minimum bid price requirement. Trading continues under the symbol 'NXGL' on the Nasdaq Capital Market.
3 min readNEXGEL, Inc. (NXGL) affiliate Adam R. Levy proposed selling 227,956 shares, valued at $41,214, and 21,500 shares, valued at $3,488.98, with sales expected around September 2026. Levy acquired shares via open-market purchases and stock grants from 2019 to 2025.
1 min readNEXGEL, INC. (NXGL) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. On September 23, 2026, NexGel, Inc. (the “Company” ) held its 2026 Special Meeting of Stockholders (the “Special Meeting” ). At the Special Meeting, there were 6,200,043 shares of common stock represented in person o
1 min readNEXGEL, INC. (NXGL) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE LANGHORNE, Pa. – August 20, 2026 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”) today announced a series of leadership, governance and strategic initiatives designed to strengthen ope
2 min readNEXGEL (NXGL) reported Q2 2026 revenue of $3.69M, up from $2.88M a year earlier, citing Celularity transaction growth and BioNX Surgical integration. The quarter showed a net loss of $2.87M, attributed to integration costs, intangible amortization, transaction expenses, and a SilverSeal inventory recall. Shares trade around $0.39, down 30% YTD.
4 min readNEXGEL, INC. (NXGL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEXGEL Reports Second Quarter 2026 Financial Results LANGHORNE, Pa. – August 17, 2026 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content
2 min readNEXGEL, INC. (NXGL) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. On July 31, 2026, NexGel, Inc. (the “ Company ”) held its 2026 Annual Meeting of Stockholders (the “ Annual Meeting ”). At the Annual Meeting, there were 6,398,925 shares of common stock represented in person or by p
2 min readNEXGEL, INC. (NXGL) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Levy Employment Agreement On July 23, 2026, NexGel, Inc. (the “ Company ”) entered into an Executive Employment Agreement w
2 min readNEXGEL, INC. (NXGL) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001468929 0001468929 2026-06-29 2026-06-29 0001468929 NXGL:CommonStockParValue0.001Member 2026-06-29 2026-06-29 0001468929 NXGL:WarrantsToPurchaseCommonStockMember 2026-06-29 2026-06-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE
2 min readLevy Adam R. (Chief Executive Officer) sold 2,000 shares of NEXGEL, INC. (NXGL) at $0.59 on 2026-06-01.
2 min read
